Relative to its peers, NVO does not have very much institutional sponsorship. The 9.76% of shares outstanding held by institutional investors is among the least of any stock in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SEI INVESTMENTS MANAGEMENT CORP. Bought 481.9 Thousand shares of Novo Nordisk
REILLY FINANCIAL ADVISORS LLC Bought 143.2 Thousand shares of Novo Nordisk
CIBC WORLD MARKETS, INC. Bought 62.3 Thousand shares of Novo Nordisk